Abstract:Importance: Although depression is a common psychiatric disorder, its underlying biological basis remains poorly understood. Pairing depression polygenic scores with the results of clinical laboratory tests can reveal biological processes involved in depression etiology and in the physiological changes resulting from depression.Objective: To characterize the association between depression polygenic scores and an inflammatory biomarker, ie, white blood cell count.Design, Setting, and Participants: This genetic association study was conducted from May 19, 2019, to June 5, 2021, using electronic health record data from 382 452 patients across 4 health care systems. Analyses were conducted separately in each health care system and meta-analyzed across all systems. Primary analyses were conducted in Vanderbilt University Medical Center's biobank. Replication analyses were conducted across 3 other PsycheMERGE sites: Icahn School of Medicine at Mount Sinai, Mass General Brigham, and the Million Veteran Program. All patients with available genetic data and recorded white blood cell count measurements were included in the analyses. Primary analyses were conducted in individuals of European descent and then repeated in a population of individuals of African descent.Exposures: Depression polygenic scores.Main Outcomes and Measures: White blood cell count.Results: Across the 4 PsycheMERGE sites, there were 382 452 total participants of European ancestry (18.7% female; median age, 57.9 years) and 12 383 participants of African ancestry (61.1% female; median age, 39.0 [range, birth-90.0 years]). A laboratory-wide association scan revealed a robust association between depression polygenic scores and white blood cell count (β, 0.03; SE, 0.004; P = 1.07 × 10-17), which was replicated in a meta-analysis across the 4 health care systems (β, 0.03; SE, 0.002; P = 1.03 × 10-136). Mediation analyses suggested a bidirectional association, with white blood cell count accounting for 2.5% of the association of depression polygenic score with depression diagnosis (95% CI, 2.2%-20.8%; P = 2.84 × 10-70) and depression diagnosis accounting for 9.8% of the association of depression polygenic score with white blood cell count (95% CI, 8.4%-11.1%; P = 1.78 × 10-44). Mendelian randomization provided additional support for an association between increased white blood count and depression risk, but depression modeled as the exposure showed no evidence of an influence on white blood cell counts.Conclusions and Relevance: This genetic association study found that increased depression polygenic scores were associated with increased white blood cell count, and suggests that this association may be bidirectional. These findings highlight the potential importance of the immune system in the etiology of depression and may motivate future development of clinical biomarkers and targeted treatment options for depression.

Immune system disruptions implicated in whole blood epigenome-wide association study of depression among Parkinson's disease patients

Epigenome-wide association study of peripheral immune cell populations in Parkinson's disease

Unraveling the transcriptomic signatures of Parkinson's disease and major depression using single-cell and bulk data

Identification and Experimental Validation of Parkinson’s Disease with Major Depressive Disorder Common Genes

DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies

Immunological shifts during early-stage Parkinson’s disease identified with DNA methylation data on longitudinally collected blood samples

Association Between Gene Polymorphism and Depression in Parkinson's Disease: A Case-Control Study

Risk of Parkinson's disease and depression severity in different populations: A two-sample Mendelian randomization analysis

Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s disease

Mir-218-5p and Mir-320A-5p As Biomarkers for Brain Disorders: Focus on the Major Depressive Disorder and Parkinson's Disease.

Immune Profiling of Parkinson’s Disease Revealed Its Association with a Subset of Infiltrating Cells and Signature Genes

Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count

Investigating the Shared Genetic Etiology Between Parkinson's Disease and Depression

Parkinson's disease-associated shifts between DNA methylation and DNA hydroxymethylation in human brain

Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms

Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease

Epigenome-wide association study, meta-analysis and risk profiling of whole blood in Parkinson's disease

Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson’s disease

Sex-dependent associations of serum BDNF, glycolipid metabolism and cognitive impairments in Parkinson's disease with depression: a comprehensive analysis

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson's Disease

Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease